ACCORD HLTHCARE FDA Approval ANDA 205873

ANDA 205873

ACCORD HLTHCARE

FDA Drug Application

Application #205873

Application Sponsors

ANDA 205873ACCORD HLTHCARE

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTIONEQ 2MG BASE/ML0CISATRACURIUM BESYLATECISATRACURIUM BESYLATE

FDA Submissions

UNKNOWN; ORIG1AP2017-06-16STANDARD

Submissions Property Types

ORIG1Null7

CDER Filings

ACCORD HLTHCARE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 205873
            [companyName] => ACCORD HLTHCARE
            [docInserts] => ["",""]
            [products] => [{"drugName":"CISATRACURIUM BESYLATE","activeIngredients":"CISATRACURIUM BESYLATE","strength":"EQ 2MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/16\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-06-16
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.